
Lipoprotein Abnormalities in Patients with Atherosclerotic Renovascular Disease
Author(s) -
Elzbieta Nowakowska Fortuna,
Hans Herlitz,
Aso Saeed,
Per-Ola Attman,
Gert Jensen,
Petar Alaupovic,
Gregor Guron
Publication year - 2011
Publication title -
kidney and blood pressure research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.806
H-Index - 51
eISSN - 1423-0143
pISSN - 1420-4096
DOI - 10.1159/000325648
Subject(s) - medicine , candesartan , endocrinology , lipoprotein , apolipoprotein b , lipoprotein(a) , triglyceride , angiotensin ii , cardiology , cholesterol , gastroenterology , blood pressure
Patients with atherosclerotic renovascular disease (ARVD) have a high risk of cardiovascular death. The primary aim was to characterize abnormalities in apolipoprotein (Apo)-defined lipoprotein (Lp) subclasses in patients with ARVD.